Evidence map›Paper›PMID 36777569›Full record

ArticleACS omega2023

Screening Multidrug Resistance Reversal Agents in Traditional Chinese Medicines by Efflux Kinetics of D-Luciferin in MCF-7/DOX

Yue Zhao, Chaoyuan Tang, Jingyi Huang, Hongyan Zhang, Jingbin Shi, Shujun Xu, Lisha Ma, Chun Peng, Qi Liu, Yang Xiong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yue ZhaoCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311258, China.
Chaoyuan TangCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311258, China.
Jingyi HuangCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311258, China.
Hongyan ZhangCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311258, China.
Jingbin ShiCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311258, China.
Shujun XuCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311258, China.
Lisha MaCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311258, China.
Chun PengSchool of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
Qi LiuDepartment of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, United States.
Yang XiongCollege of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 311258, China.ORCID https://orcid.org/0000-0002-9508-1987

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, we established a simple and rapid

Identifiers

PMID36777569
PMCPMC9909823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.